2 results
Approved WMORecruiting
1 Primary objectiveTo demonstrate that the minimally invasive surgical procedure in combination with the use of the BA400 abutment is associated with a reduction of inflammation/ infection, overgrowth, pain and numbness at the site of implantation…
Not approvedWill not start
Primary:To compare the efficacy of abrocitinib 200 mg once daily (QD) versus dupilumab (as per label guidelines) in adult participants on background topical therapy with moderate to severe atopic dermatitis (AD).Key SecondaryTo compare the efficacy…